Onconic Therapeutics, Inc.

Onconic Therapeutics, Inc. financial statements

Onconic Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueKRW 53.39BEODHD
Net incomeKRW 15.78BEODHD
Cash and equivalentsKRW 47.05BEODHD

Onconic Therapeutics, Inc. financials on 6ix · Onconic Therapeutics, Inc. on 6ix